The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model

J Clin Endocrinol Metab. 2013 Mar;98(3):E472-84. doi: 10.1210/jc.2012-3462. Epub 2013 Jan 24.

Abstract

Context: The inflammatory cytokine IL-6 is related to ovarian hyperstimulation syndrome (OHSS), although the functional role of IL-6 in OHSS remains largely unknown.

Objective: A key feature of the IL-6 response is that its regulation is dependent on IL-6 trans-signaling via soluble IL-6 receptor-α (sIL-6Rα). The objective of the study was to elucidate the mechanistic role of IL-6 trans-signaling in the vascular leakage that underlies the pathophysiology of OHSS.

Design: Ovarian endothelial cells (ECs) and granulosa-lutein cells were obtained from women undergoing in vitro fertilization. OHSS was induced in mice by administering gonadotropins for 2 days followed by human chorionic gonadotropin. The functional role of IL-6 trans-signaling in OHSS was verified using the designer cytokines Hyper IL-6 and sgp130-Fc.

Results: The follicular fluid levels of sIL-6Rα were elevated in women at high risk for OHSS. In the murine OHSS model, stimulation with gonadotropins significantly induces ovarian IL-6 and sIL-6Rα expression. In vitro, FSH induces de novo sIL-6Rα synthesis in granulosa-lutein cells through a protein kinase C-dependent pathway. In addition, sIL-6Rα was released by leukocytes in the presence of conditioned medium from human chorionic gonadotropin-treated granulosa-lutein cells. Ovarian ECs responded to the IL-6Rα-IL-6 complex (Hyper IL-6) but not to IL-6 alone. With activation of signal transducer and activator of transcription 3 (STAT3) and ERK, Hyper IL-6 increased vascular endothelial growth factor expression and the vascular permeability of ECs. Selective blockade of IL-6 trans-signaling by sgp130-Fc significantly inhibited vascular endothelial growth factor expression and prevented OHSS in mice.

Conclusions: IL-6 trans-signaling is activated during the ovarian stimulation process. Our findings provide insight into the biologic effects of IL-6 trans-signaling in OHSS and highlight that IL-6 trans-signaling can induce vascular leakage in this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillary Permeability / immunology
  • Chorionic Gonadotropin / pharmacology
  • Cytokine Receptor gp130 / metabolism
  • Disease Models, Animal
  • Endothelial Cells / cytology
  • Endothelial Cells / immunology
  • Endothelial Cells / metabolism
  • Female
  • Follicle Stimulating Hormone / pharmacology
  • Follicular Fluid / immunology
  • Follicular Fluid / metabolism
  • Granulosa Cells / cytology
  • Granulosa Cells / immunology
  • Granulosa Cells / metabolism
  • Hormones / pharmacology
  • Humans
  • Interleukin-6 / immunology
  • Interleukin-6 / metabolism*
  • Mice
  • Mice, Inbred ICR
  • Ovarian Hyperstimulation Syndrome / epidemiology
  • Ovarian Hyperstimulation Syndrome / immunology*
  • Ovarian Hyperstimulation Syndrome / metabolism*
  • Ovulation Induction / methods
  • Protein Kinase C / metabolism
  • Receptors, Interleukin-6 / immunology
  • Receptors, Interleukin-6 / metabolism
  • Reproductive Control Agents / pharmacology
  • Risk Factors
  • Signal Transduction / immunology*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Chorionic Gonadotropin
  • Hormones
  • IL6 protein, human
  • IL6R protein, human
  • Interleukin-6
  • Receptors, Interleukin-6
  • Reproductive Control Agents
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • interleukin-6, mouse
  • vascular endothelial growth factor A, mouse
  • Cytokine Receptor gp130
  • Follicle Stimulating Hormone
  • Protein Kinase C